Courtesy of Benzinga.
Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating.
The target price for Applied DNA Sciences is set to $5.
Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.
Applied DNA Sciences’ shares rose 2.41 percent to close at $2.55 on Friday.
Latest Ratings for APDN
Date | Firm | Action | From | To |
---|---|---|---|---|
May 2015 | Benchmark | Initiates Coverage on | Sell |
View More Analyst Ratings for APDN
View the Latest Analyst Ratings
Posted-In: BenchmarkInitiation Analyst Ratings